Relesium, a new gut-health solution for GLP-1 users, is available as an all-natural dietary supplement designed to alleviate occasional gastrointestinal (GI) issues and support gut health. With its patented formula, Relesium offers a targeted, safe, and clinically backed solution for individuals experiencing occasional digestive side effects, such as nausea, diarrhea, constipation, and bloating, from GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro®, and other semaglutides and tirzepatides.

GLP-1 medications, widely prescribed for diabetes management, weight loss, and reducing cardiovascular risks, have been taken by over 34 million Americans, according to a May 2024 Kaiser Family Foundation Health Tracking Poll. These drugs have transformed healthcare for many but may often cause GI symptoms like nausea, diarrhea, and constipation. A Harvard Health report confirms that these symptoms are the most common complaints among GLP-1 users, with up to half of patients reporting discomfort.

“Relesium is a game changer for individuals taking GLP-1 medications and experiencing gastrointestinal issues. It’s the first product to market with proven science specifically designed to target GI distress that many patients experience,” said Dr. Harry Oken, an internist, Adjunct Professor of Medicine at the University of Maryland, and former Chair of the Department of Medicine at Johns Hopkins Howard County Medical Center. “While other formulas are untested or lack scientific backing to ensure they provide support for side effects, Relesium stands apart. I’ve seen Relesium address the root causes of my patients’ GI discomfort, allowing them to quickly feel their best while administering GLP-1 medications.”

Relesium is formulated to provide both immediate relief and lasting gut support. Its patented formula:

  • Eases digestive discomfort such as occasional nausea, diarrhea, bloating, and constipation
  • Neutralizes harmful pathogens in the gut
  • Strengthens intestinal lining and stabilizes gut integrity
  • Enhances nutrient absorption for optimal health
  • Supports a balanced gut microbiome with prebiotic-rich ingredients

When taken as directed, Relesium has been shown to significantly reduce the occasional adverse GI-related symptoms of GLP-1 medications, providing much-needed relief without compromising the efficacy of the drugs.

“We’re committed to providing real solutions that address the pervasive gut-health challenges faced by millions of people, including those challenges brought on by GLP-1 drugs,” said Tom Feeley, CEO for PanTheryx, the company behind Relesium. “Relesium is unlike any other gut health product on the market. It is not a probiotic or digestive enzyme. It utilizes all-natural ingredients provided by mother nature, is efficacious, and fast acting in providing relief.”

Leaning into PanTheryx’s rich history in using novel ingredients for digestive health, Relesium’s unique combination of antibody-rich chicken egg powder and bovine colostrum offers a synergistic approach to gut health. These ingredients are rich in antibodies, anti-microbial peptides, growth factors, and numerous proteins, vitamins, minerals, and prebiotics that quickly neutralize toxins, stabilize the gut, and promote intestinal strength and healthy permeability. Clinical findings demonstrate the product’s ability to significantly reduce digestive discomfort and enhance nutrient absorption, making it a valuable addition to the daily routine of anyone experiencing occasional GI distress.

Relesium is now available through its website for $44.99 and is expanding to retailers soon. To learn more about Relesium, go to Relesium.com, or for more information on PanTheryx’s other consumer brands, visit PanTheryx.com.